secwatch.observer — SEC 8-K summary
======================================

Issuer:     USANA HEALTH SCIENCES INC (USNA)
CIK:        0000896264
Form:       8-K
Filed at:   2025-04-22T23:59:59+00:00
Accession:  0000896264-25-000119
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

USANA Q1 net sales up 10% to $250M; EPS down 43% to $0.49; reiterates FY outlook
--------------------------------------------------------------------------------

- Net sales $250M (+10% YoY); net earnings $9.4M (-43%); diluted EPS $0.49 vs $0.86.
- Adjusted diluted EPS $0.73 (-15%); adjusted EBITDA $30M (-10%).
- Direct selling Active Customers 459,000 (-7%); Hiya Active Monthly Subscribers 224,000.
- FY2025 outlook reaffirmed: consolidated net sales $920M-$1.0B, diluted EPS $1.50-$2.20.
- Repurchased 399,000 shares for $12M; $49M remaining under authorization.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896264/000089626425000119/0000896264-25-000119-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896264/000089626425000119/usna-20250422.htm
  HTML page:      https://secwatch.observer/filing/0000896264-25-000119

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer